J-FORCE study: A randomized, double-blind, placebo-controlled phase III study evaluating olanzapine (5 mg) combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based, highly emetogenic chemotherapy

Autor:	Takuhiro Yamaguchi, Yuichiro Ohe, T. Yanai, Sadamoto Zenda, M. Abe, Hironobu Hashimoto, Satoru Iwasa, Haruhiko Fukuda, H. Kaba, Hiroyuki Terakado
Rok vydání:	2017
Předmět:	Cisplatin Olanzapine Antiemetic Agent medicine.drug_class business.industry Hematology Placebo Chemotherapy regimen Double blind Oncology Anesthesia medicine Antiemetic business medicine.drug Chemotherapy-induced nausea and vomiting
Zdroj:	Annals of Oncology. 28:v564-v565
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a120d6766342481d463efb9998926177 https://doi.org/10.1093/annonc/mdx388.064 Zobrazit plný text záznamu